| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
AIDS Research Center, National Institute of Infectious Diseases, Tokyo;
Chemo-Sero-Therapeutic Research Institute, Kyokushi Kikuchi, Kumamoto;
Department of Veterinary Science, National Institute of Infectious Diseases, Tokyo, Japan;
§
Department of Immunology and Microbiology, Meiji College of Oriental Medicine, Kyoto; and
¶
Department of Immunology, Institute of Chest Diseases, Kyoto University, Kyoto, Japan
Using SCID-hu mice, it was tested whether humanized mAb Rµ5.5 could prevent infection by HIV-1 i.v. inoculation. The Ab that recognizes the IHIGPGRAFYT motif in the principal neutralizing determinant (PND) of HIVMN, as well as the original mouse mAb µ5.5, neutralized HIVMN with high activity. Seven primary field isolates from Japanese hemophiliacs seropositive for HIV-1 clade B were compared for their reactivities to Rµ5.5. Rµ5.5 was effective, particularly against the viruses that matched amino acid sequences of the PND region of HIV-1, and it completely neutralized primary isolates. Moreover, the passive transfer of the Ab elicited protection against challenge by the primary isolates in SCID-hu or hu-PBL-SCID mice after i.v. inoculation with the virus by both quantitative PCR and PBMC-based virus isolation in vitro. Further, inoculation with the Ab also prevented the atrophic change in the medulla of the thymic transplant that was induced by i.v. inoculation of the virus. Thus, the humanized neutralizing Ab Rµ5.5 appears to protect SCID-hu mice from infection by primary field isolates.
This article has been cited by other articles:
|
|
 |
|
  Y. Eda, T. Murakami, Y. Ami, T. Nakasone, M. Takizawa, K. Someya, M. Kaizu, Y. Izumi, N. Yoshino, S. Matsushita, et al. Anti-V3 Humanized Antibody KD-247 Effectively Suppresses Ex Vivo Generation of Human Immunodeficiency Virus Type 1 and Affords Sterile Protection of Monkeys against a Heterologous Simian/Human Immunodeficiency Virus Infection. J. Virol., June 1, 2006; 80(11): 5563 - 5570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Someya, D. Cecilia, Y. Ami, T. Nakasone, K. Matsuo, S. Burda, H. Yamamoto, N. Yoshino, M. Kaizu, S. Ando, et al. Vaccination of Rhesus Macaques with Recombinant Mycobacterium bovis Bacillus Calmette-Guerin Env V3 Elicits Neutralizing Antibody-Mediated Protection against Simian-Human Immunodeficiency Virus with a Homologous but Not a Heterologous V3 Motif J. Virol., February 1, 2005; 79(3): 1452 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lapenta, S. M. Santini, M. Logozzi, M. Spada, M. Andreotti, T. Di Pucchio, S. Parlato, and F. Belardelli Potent Immune Response against HIV-1 and Protection from Virus Challenge in hu-PBL-SCID Mice Immunized with Inactivated Virus-pulsed Dendritic Cells Generated in the Presence of IFN-{alpha} J. Exp. Med., July 21, 2003; 198(2): 361 - 367. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Okamoto, D. C. Douek, R. D. McFarland, and R. A. Koup Effects of exogenous interleukin-7 on human thymus function Blood, April 15, 2002; 99(8): 2851 - 2858. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Glamann and V. M. Hirsch Characterization of a Macaque Recombinant Monoclonal Antibody That Binds to a CD4-Induced Epitope and Neutralizes Simian Immunodeficiency Virus J. Virol., August 1, 2000; 74(15): 7158 - 7163. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
